Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05310838 · ClinicalTrials.gov registry record · NA

Optimizing Engagement in Services for First-Episode Psychosis

A NA study of First Episode Psychosis and Engagement, Patient, sponsored by California State University, San Bernardino.

Active
Registry status
NA
Development phase
58
Enrollment target
2
Study locations

NCT05310838 is a NA study of First Episode Psychosis and Engagement, Patient that is active but no longer recruiting, run by California State University, San Bernardino. The registered enrollment target is 58 participants, below the 6,426-participant average among 8 other First Episode Psychosis trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05310838, a NA study of First Episode Psychosis and Engagement, Patient, is active but no longer recruiting, sponsored by California State University, San Bernardino.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
58 participants
Enrollment target
2
Study locations

Study Summary

This study will compare a 12-session behavioral activation (BA) intervention modified for first-episode psychosis (FEP) to usual community mental health care (i.e., treatment-as-usual; TAU) delivered over 6 months with a sample of Latinos with FEP and their families. Comparable family group sessions will also be delivered to participants in both conditions. It is expected that BA participants will show better engagement than TAU participants.

Conditions Studied

First Episode Psychosis Engagement, Patient

Interventions

  • BEHAVIORAL Treatment As Usual
  • BEHAVIORAL Behavioral Activation for First Episode Psychosis

Study Locations (2)

California

  • San Fernando Mental Health Center - Granada Hills
  • Olive View - UCLA Medical Center - Sylmar

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2022-03-01
Est. Completion 2026-06-30
Phase NA

Sponsor

California State University, San Bernardino

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05310838

The ClinicalTrials.gov registry entry for NCT05310838 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,426-participant average among 8 other First Episode Psychosis trials with a reported enrollment target (99% lower). The listed sponsor is California State University, San Bernardino, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with First Episode Psychosis appearing as the primary indexed condition, and to 2 interventions - of which Treatment As Usual is the first listed.

NCT05310838 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05310838 about?

NCT05310838 is a clinical study titled "Optimizing Engagement in Services for First-Episode Psychosis". This study will compare a 12-session behavioral activation (BA) intervention modified for first-episode psychosis (FEP) to usual community mental health care (i.e., treatment-as-usual; TAU) delivered over 6 months with a sample of Latinos with FEP and their families. Comparable family group sessions...

What is the current status of trial NCT05310838?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 58 participants. The study started on 2022-03-01. Estimated completion is 2026-06-30.

What conditions does trial NCT05310838 study?

This clinical trial studies the following conditions: First Episode Psychosis, Engagement, Patient.

What interventions are being tested in trial NCT05310838?

The interventions under investigation include: Treatment As Usual (BEHAVIORAL), Behavioral Activation for First Episode Psychosis (BEHAVIORAL).

Who is sponsoring clinical trial NCT05310838?

This trial is sponsored by California State University, San Bernardino, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05310838 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for First Episode Psychosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

First Episode Psychosis

All registered trials for this condition

Engagement, Patient

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.